enGene Holdings: Key Catalysts Incoming For 2026

Group 1 - The article expresses an optimistic view on enGene Holdings Inc. (ENGN), reaffirming a "Buy" sentiment after a period of significant momentum [1] - The author has a PhD in biochemistry and extensive experience analyzing clinical trials and biotech companies, emphasizing the importance of understanding the science behind investments [1] Group 2 - The article aims to educate readers on the potential pitfalls of investing in the biotech sector, highlighting the need for due diligence [1]